Evaluation of a novel transseptal puncture device for use in cardiac procedures requiring left atrial access

Transseptal puncture (TSP) is the first step in percutaneous left-heart interventions including atrial fibrillation ablation, left atrial appendage occlusion, and percutaneous mitral valve repair/replacement. Current TSP techniques remain limited by suboptimal imaging visualization, lack of precise control over puncture sites, and a steep learning curve. The Protaryx transseptal puncture device was designed to address these limitations by incorporating a novel atraumatic highly echogenic deployable and retractable nitinol mesh end effector mounted on an extendable catheter. The key advantages of the Protaryx TSP device are the maneuverability of the extendable catheter and the visibility of the end effector that combine to enable precise targeting of the fossa ovalis during TSP. Here, we provide an overview of challenges with transseptal puncture, an overview of the Protaryx device, and early clinical evidence. This includes results of the 5-patient prospective non-randomized observational first-in-human experience with the Protaryx TSP catheter. This study demonstrated early feasibility and safety, with rapid on-target puncture of the fossa ovalis, zero adverse events, and 100% success of structural heart interventions following TSP. The United States Food and Drug Administration (FDA) approval of the Protaryx device has increased options for interventional cardiologists and electrophysiologists seeking to streamline left-sided structural heart intervention.

Authors

Institutions

Publication Details

Journal
Future Cardiology
Published
2026-11-14
DOI
https://doi.org/10.1080/14796678.2026.2755225
Primary Topic
Cardiac Arrhythmias and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Evaluation of a novel transseptal puncture device for use in cardiac procedures requiring left atrial access

Chetan Pasrija, James Stuart Gammie, AlleaBelle Bradshaw, Gagan Deep Singh et al.
Future Cardiology
Cardiac Arrhythmias and Treatments
article

Evaluation of a novel transseptal puncture device for use in cardiac procedures requiring left atrial access

Chetan Pasrija, James Stuart Gammie, AlleaBelle Bradshaw, Gagan Deep Singh, Rachael W. Quinn, Cameron Purcell, Adrian Ebner, Christopher Rumer, David Mester
article en

Abstract

Transseptal puncture (TSP) is the first step in percutaneous left-heart interventions including atrial fibrillation ablation, left atrial appendage occlusion, and percutaneous mitral valve repair/replacement. Current TSP techniques remain limited by suboptimal imaging visualization, lack of precise control over puncture sites, and a steep learning curve. The Protaryx transseptal puncture device was designed to address these limitations by incorporating a novel atraumatic highly echogenic deployable and retractable nitinol mesh end effector mounted on an extendable catheter. The key advantages of the Protaryx TSP device are the maneuverability of the extendable catheter and the visibility of the end effector that combine to enable precise targeting of the fossa ovalis during TSP. Here, we provide an overview of challenges with transseptal puncture, an overview of the Protaryx device, and early clinical evidence. This includes results of the 5-patient prospective non-randomized observational first-in-human experience with the Protaryx TSP catheter. This study demonstrated early feasibility and safety, with rapid on-target puncture of the fossa ovalis, zero adverse events, and 100% success of structural heart interventions following TSP. The United States Food and Drug Administration (FDA) approval of the Protaryx device has increased options for interventional cardiologists and electrophysiologists seeking to streamline left-sided structural heart intervention.

Future Cardiology
Johns Hopkins University (US), University of California System (US), Holy Family Hospital Nazareth (IL), Protip Medical (France) (FR)
Cardiac Arrhythmias and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon